The objective for this study is to evaluate the efficacy, pharmacokinetics, safety and tolerability of HSY244 to restore sinus rhythm in patients with Atrial Fibrillation (AF). The study subjects have current ongoing episodes of AF for more than 6 hours and less than 30 days.
Principal investigatorDr. John Ip, MD, FACC
Trial CategoryHeart & Vascular
Trial SubCategoryAtrial Fibrillation